Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gddy Stock Analysis Godaddy Inc. Web Hosting Stock Posts Modest Gain At 81.67 Level 20260403 1 Arr Stock Analysis Armour Residential Reit Inc Posts 1.54 Percent Gain To Hit 17.14 Price Level 20260403 1 Is Fortinet Ftnt Stock Near Support Price At 82.36 Down 0.21 20260406 Is Delek Us Dk Stock Consolidating Price At 42.50 Up 1.82 20260413 Is Zymeworks Zyme Stock Good For Portfolio Price At 25.84 Up 0.16 20260406 Pediatrix Medical Group Inc MD climbs nearly four percent even after Q4 2025 EPS misses consensus analyst estimates Bladex BLX Stock Directional Bias Review Mini Rally 20260418 Market Update Tech leads gains as consumer sectors lag in mixed trade The quality metrics hidden in Strategy STRF earnings Q1 2026 EPS Misses Estimates AutoZone AZO Stock Accelerating Trend Weakens 20260420 MVIS MicroVision shares rise 624 percent despite Q4 2025 EPS miss and 74 percent year over year revenue drop Netflix Inc NFLX MNDY mondaycom Q4 2025 earnings outperform expectations as shares climb 277 percent on 268 percent yearoveryear revenue growth Enphase Energy ENPH Stock Is It Worth Investing In Q4 2025 Earnings Beat Estimates POLA Polar Power gains 165 in todays trading following its Q3 2023 earnings report MRX Marex delivers 94 percent Q4 2025 EPS beat yet shares drop 161 percent on muted investor reaction Why M3Brigade MBVI looks solid from every angle Quiet 20260506 BankMontreal BMO Q1 earnings beat forecasts but stock slips 164 despite 127 revenue growth Target Corporation TGT Bullish 10Year Outlook Signals Potential 500 Upside by 2036 Assured Guar AGO Delivers Q1 2026 Beat EPS 250 vs 169 Expected Trump Exclusive Iran Conflict Could Delay Interest Rate Plans Intel Stake Regret Revealed DeepSeek Wont Sink US AI Titans Why the Selloff Is Overblown Ryan Cohens eBay Pursuit Faces Mounting Skepticism From Market Analysts Chain Bridge CBNA Q1 2026 Earnings EPS 108 Beats Estimates Revolution RVMDW Slides 890 as Selling Pressure Mounts 20260517 OneMain Holdings OMF Rallies 264 as Bulls Target 5652 20260514 Univest UVSP Q1 2026 Earnings Why the Beat Matters Masco Corporation Wall Street Sentiment Assessed Amid Home Improvement Market Shifts Wheeler WHLR Q2 2024 In Line Whats Next for Investors Africas Payments Paradox Complexity as Catalyst for Market Growth Willis WTW Delivers Q1 2026 Beat EPS 372 vs 370 Expected Kevin Warsh Faces Tense Federal Reserve Debate Over Interest Rate Cuts Amid Inflation Surge Bond Market Signals Concern Over Fed Inflation Stance as Warsh Assumes Role Leonardo Secures 320 Million Contract to Equip Kuwait Patrol Vessels Bolstering Italys Gulf Presence Treasury Yields Decline on PostHoliday Trading as Geopolitical Hopes Resurface Boise Cascade Shares Slide 23 as Major Investor Cuts Stake by 27 Million Sera Prognostics Q1 2026 Earnings InLine Loss No Revenue Stock Surges 15 CRDL Q4 2025 Earnings Loss Narrows as EPS Beats Estimates by 142 FRPT Q1 2026 Earnings Steep Earnings Miss Highlights Cost Pressures at Freshpet CheckCap Ltd MBAI Q3 2023 Earnings EPS Misses Estimates as PreRevenue Company Continues RD Efforts Harrow Inc Q1 2026 Earnings Pharmaceutical Firm Misses EPS Estimates by Wide Margin Belpointe PREP OZ Holds Steady Near 48 as OZ Fund Trades in Tight Range DWS Municipal Income Trust KTF Holds Steady Near Key Resistance in Quiet Session Cathay General Bancorp CATY Holds Steady Near Support Eyes Resistance Ahead Piper Sandler PIPR Declines 101 as Stock Hovers Near Support Testing Recent Lows Why Pimco PML ability to innovate sets it apart Investor Interest 20260506 DexCom Inc DXCM Poised for Incremental Revenue Growth Amid 115 Projected CAGR in MENA Continuous Glucose Monitoring Market Through 2034 NAMM Namib Minerals highlights longterm commodity demand upside in its latest quarterly earnings update WK Workiva delivers 102 percent Q4 2025 EPS beat shares rise 239 percent on upbeat investor sentiment Pfizer Inc PFE Why the Undervalued Pharma Giant May Outperform Eli Lilly and Novo Nordisk